Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Gastroenterology. 2008 Sep 13;135(6):1953–1960. doi: 10.1053/j.gastro.2008.08.057

Figure 2. Kaplan Meier Survival Analysis.

Figure 2

30-day mortality (vertical hashed line) was not significantly different between placebo (solid line) and etanercept (hashed line) groups. 6-month mortality rate was significantly higher in the etanercept arm compared to the placebo arm (p<0.05).